Highlights

  • Third quarter 2026 Net Income was $509.0 million, including a net unrealized gain on digital Assets of $533.7 million.
  • The nine-month 2026 net loss was $14.5 million, and the net loss attributable to common stockholders was $88.4 million.
  • The company recognized a $14.7 million Impairment of an acquired medical device research intangible asset in the third quarter.
  • On October 20, 2026, the company completed a 7,000,000-share SATS preferred offering with net proceeds of approximately $609.0 million.

Strive, Inc. (NASDAQ:ASST) shares were trading at USD 14.90 on November 20, 2026, down 10.30%, with a relative Volume at time of 2.22. The company, which holds a Bitcoin treasury, completed its SATS preferred stock offering on October 20, 2026 and filed its report for the quarter ended September 30, 2026 on November 6, 2026.

Strive, Inc. is a Nevada corporation with principal executive offices in Dallas, Texas. It describes itself as a structured finance company and institutional asset manager with a Bitcoin-focused treasury strategy. Through wholly-owned subsidiaries, including Strive Asset Management, LLC, a registered investment advisor, it provides sub-advisory services for the Strive funds, a series of exchange traded funds. It acquired Semler Scientific, Inc. on January 16, 2026. The company issues SATA Stock and SATS Stock, which are perpetual preferred Equity instruments, and reports on a fiscal year ended December 31. As of September 30, 2026, it managed over $2.9 billion in assets under management.

Third Quarter 2026 Results

The company's statements present the Successor three months ended September 30, 2026 alongside the Successor period from September 12, 2025 to September 30, 2025 and the Predecessor period from July 1, 2025 to September 11, 2025. The filing states that the periods may not be comparable given the Asset Entities Merger and the Semler Scientific Merger.

For the three months ended September 30, 2026, total revenues were $2.7 million, including investment advisory fees of $1.6 million and medical device revenues of $1.1 million. Total operating expenses were $38.7 million, including the $14.7 million impairment of the medical device Research and Development intangible asset.

Total investment gains were $544.0 million, including a net unrealized gain on digital assets of $533.7 million and a net unrealized gain on investments in preferred equity of $8.8 million. Net Operating Income was $508.0 million and net income was $509.0 million. After dividends on preferred stock of $34.2 million, net income attributable to common stockholders was $474.8 million, or $5.33 basic and $5.24 diluted per share.

Nine-Month Results

For the nine months ended September 30, 2026, total revenues were $8.4 million and total operating expenses were $83.7 million. Total investment gains were $11.9 million, including a net unrealized gain on digital assets of $9.9 million.

The net operating loss was $63.4 million and the net loss was $14.5 million. Net loss attributable to common stockholders was $88.4 million, or $1.17 per basic and diluted share. The company stated that in the third quarter it terminated research and development efforts on an in-development medical device product acquired in the Semler Scientific Merger, and it recognized the impairment charge.

Balance Sheet and Bitcoin Holdings

At September 30, 2026, cash and cash equivalents were $285.4 million, compared with $67.5 million at December 31, 2025. Total assets were $2.68 billion, total liabilities were $37.5 million and total stockholders' equity was $1.44 billion.

The company stated that it acquired 8,136 bitcoin at an average cost of $78,885 per bitcoin during the third quarter and held 28,000 bitcoin at September 30, 2026. It stated that digital assets at Fair Value totaled approximately $2.3 billion.

Capital Markets and Subsequent Events

During the third quarter, the company issued 14.4 million shares of Class A common stock for aggregate gross proceeds of $271.6 million and 5.1 million shares of SATA Stock for aggregate gross proceeds of $511.2 million under its at-the-market programs.

On October 20, 2026, the company completed a registered public offering of 7,000,000 shares of its 15.00% Series A Perpetual SATS Preferred Stock for net proceeds of approximately $609.0 million. On October 26, 2026, it entered into a sales agreement for SATS Stock having an aggregate sales price of up to $1.0 billion.

From October 1, 2026 to October 30, 2026, the company purchased 15,124 bitcoin at an average price of approximately $83,310 per bitcoin. As of October 30, 2026, it held $490.4 million of cash and cash equivalents and a bitcoin treasury of 43,124 bitcoin.